Provider: NIHR Journals Library
Content:text/plain; charset="UTF-8"
TY  - JOUR
LB  - 1.
AU  - Cornelius, V
AU  - Wilson, R
AU  - Cro, S
AU  - Barker, J
AU  - Burden, D
AU  - Griffiths, CEM
TI  - A small population, randomised, placebo-controlled trial to determine the efficacy of anakinra in the treatment of pustular psoriasis: study protocol for the APRICOT trial
J2  - Trials
PY  - 2018
VL  - 19
SP  - 465
UR  - https://doi.org/10.1186/s13063-018-2841-y
ER  - 
TY  - JOUR
LB  - 2.
AU  - Cro, S
AU  - Cornelius, VR
AU  - Pink, AE
AU  - Wilson, R
AU  - Pushpa-Rajah, A
AU  - Patel, P
TI  - Anakinra for palmoplantar pustulosis: results from a randomized, double-blind, multicentre, two-staged, adaptive placebo-controlled trial (APRICOT)
J2  - Br J Dermatol
PY  - 2022
VL  - 186
SP  - 245
EP  - 256
UR  - https://doi.org/10.1111/bjd.20653
ER  - 
TY  - ELEC
LB  - 3.
AU  - NHS UK
TI  - Psoriasis – Overview
PY  - 2018
UR  - www.nhs.uk/conditions/psoriasis/
M1  - 1 May 2020
ER  - 
TY  - JOUR
LB  - 4.
AU  - Bhutani, T
AU  - Patel, T
AU  - Koo, B
AU  - Nguyen, T
AU  - Hong, J
AU  - Koo, J
TI  - A prospective, interventional assessment of psoriasis quality of life using a nonskin-specific validated instrument that allows comparison with other major medical conditions
J2  - J Am Acad Dermatol
PY  - 2013
VL  - 69
SP  - e79
EP  - e88
UR  - https://doi.org/10.1016/j.jaad.2012.10.009
ER  - 
TY  - JOUR
LB  - 5.
AU  - Griffiths, C
AU  - Christophers, E
AU  - Barker, J
AU  - Chalmers, R
AU  - Chimenti, S
AU  - Krueger, G
TI  - A classification of psoriasis vulgaris according to phenotype
J2  - Br J Dermatol
PY  - 2007
VL  - 156
SP  - 258
EP  - 262
UR  - https://doi.org/10.1111/j.1365-2133.2006.07675.x
ER  - 
TY  - JOUR
LB  - 6.
AU  - Navarini, AA
AU  - Burden, AD
AU  - Capon, F
AU  - Mrowietz, U
AU  - Puig, L
AU  - Köks, S
TI  - European consensus statement on phenotypes of pustular psoriasis
J2  - J Eur Acad Dermatol Venereol
PY  - 2017
VL  - 31
SP  - 1792
EP  - 1799
UR  - https://doi.org/10.1111/jdv.14386
ER  - 
TY  - JOUR
LB  - 7.
AU  - Menter, A
AU  - Gottlieb, A
AU  - Feldman, S
AU  - Voorhees, A
AU  - Leonardi, C
AU  - Gordon, K
TI  - Guidelines of care for the management of psoriasis and psoriatic arthritis: section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics
J2  - J Am Acad Dermatol
PY  - 2008
VL  - 58
SP  - 826
EP  - 850
UR  - https://doi.org/10.1016/j.jaad.2008.02.039
ER  - 
TY  - JOUR
LB  - 8.
AU  - Sampogna, F
AU  - Gisondi, P
AU  - Melchi, CF
AU  - Amerio, P
AU  - Girolomoni, G
AU  - Abeni, D
TI  - Prevalence of symptoms experienced by patients with different clinical types of psoriasis
J2  - Br J Dermatol
PY  - 2004
VL  - 151
SP  - 594
EP  - 599
UR  - https://doi.org/10.1111/j.1365-2133.2004.06093.x
ER  - 
TY  - JOUR
LB  - 9.
AU  - Farley, E
AU  - Masrour, S
AU  - McKey, J
AU  - Menter, A
TI  - Palmoplantar psoriasis: a phenotypical and clinical review with introduction of a new quality-of-life assessment tool
J2  - J Am Acad Dermatol
PY  - 2009
VL  - 60
SP  - 1024
EP  - 1031
UR  - https://doi.org/10.1016/j.jaad.2008.11.910
ER  - 
TY  - JOUR
LB  - 10.
AU  - Sampogna, F
AU  - Tabolli, S
AU  - Söderfeldt, B
AU  - Axtelius, B
AU  - Aparo, U
AU  - Abeni, D
TI  - Measuring quality of life of patients with different clinical types of psoriasis using the SF-36
J2  - Br J Dermatol
PY  - 2006
VL  - 154
SP  - 844
EP  - 849
UR  - https://doi.org/10.1111/j.1365-2133.2005.07071.x
ER  - 
TY  - JOUR
LB  - 11.
AU  - Rapp, S
AU  - Feldman, S
AU  - Exum, M
AU  - Fleischer, A
AU  - Reboussin, D
TI  - Psoriasis causes as much disability as other major medical diseases
J2  - J Am Acad Dermatol
PY  - 1999
VL  - 41
SP  - 401
EP  - 407
UR  - https://doi.org/10.1016/S0190-9622(99)70112-X
ER  - 
TY  - JOUR
LB  - 12.
AU  - Tsoi, LC
AU  - Spain, SL
AU  - Knight, J
AU  - Ellinghaus, E
AU  - Stuart, PE
AU  - Capon, F
TI  - Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity
J2  - Nat Genet
PY  - 2012
VL  - 44
SP  - 1341
EP  - 1348
UR  - https://doi.org/10.1038/ng.2467
ER  - 
TY  - JOUR
LB  - 13.
AU  - Obeid, G
AU  - Do, G
AU  - Kirby, L
AU  - Hughes, C
AU  - Sbidian, E
AU  - Le Cleach, L
TI  - Interventions for chronic palmoplantar pustulosis
J2  - Cochrane Database Syst Rev
PY  - 2020
VL  - 1
UR  - https://doi.org/10.1002/14651858.CD011628.pub2
ER  - 
TY  - JOUR
LB  - 14.
AU  - Li, M
AU  - Han, J
AU  - Lu, Z
AU  - Li, H
AU  - Zhu, K
AU  - Cheng, R
TI  - Prevalent and rare mutations in IL-36RN gene in Chinese patients with generalized pustular psoriasis and psoriasis vulgaris
J2  - J Invest Dermatol
PY  - 2013
VL  - 133
SP  - 2637
EP  - 2639
UR  - https://doi.org/10.1038/jid.2013.267
ER  - 
TY  - JOUR
LB  - 15.
AU  - Onoufriadis, A
AU  - Simpson, MA
AU  - Pink, AE
AU  - Di Meglio, P
AU  - Smith, CH
AU  - Pullabhatla, V
TI  - Mutations in IL36RN/IL1F5 are associated with the severe episodic inflammatory skin disease known as generalized pustular psoriasis
J2  - Am J Hum Genet
PY  - 2011
VL  - 89
SP  - 432
EP  - 437
UR  - https://doi.org/10.1016/j.ajhg.2011.07.022
ER  - 
TY  - JOUR
LB  - 16.
AU  - Marrakchi, S
AU  - Guigue, P
AU  - Renshaw, BR
AU  - Puel, A
AU  - Pei, XY
AU  - Fraitag, S
TI  - Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis
J2  - N Engl J Med
PY  - 2011
VL  - 365
SP  - 620
EP  - 628
UR  - https://doi.org/10.1056/NEJMoa1013068
ER  - 
TY  - JOUR
LB  - 17.
AU  - Albanesi, C
AU  - Madonna, S
AU  - Gisondi, P
AU  - Girolomoni, G
TI  - The interplay between keratinocytes and immune cells in the pathogenesis of psoriasis
J2  - Front Immunol
PY  - 2018
VL  - 9
SP  - 1549
UR  - https://doi.org/10.3389/fimmu.2018.01549
ER  - 
TY  - JOUR
LB  - 18.
AU  - Dinarello, CA
AU  - Simon, A
AU  - van der Meer, JW
TI  - Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases
J2  - Nat Rev Drug Discov
PY  - 2012
VL  - 11
SP  - 633
EP  - 652
UR  - https://doi.org/10.1038/nrd3800
ER  - 
TY  - JOUR
LB  - 19.
AU  - Johnston, A
AU  - Xing, X
AU  - Wolterink, L
AU  - Barnes, DH
AU  - Yin, Z
AU  - Reingold, L
TI  - IL-1 and IL-36 are dominant cytokines in generalized pustular psoriasis
J2  - J Allergy Clin Immunol
PY  - 2017
VL  - 140
SP  - 109
EP  - 120
ER  - 
TY  - JOUR
LB  - 20.
AU  - Tauber, M
AU  - Viguier, M
AU  - Alimova, E
AU  - Petit, A
AU  - Lioté, F
AU  - Smahi, A
AU  - Bachelez, H
TI  - Partial clinical response to anakinra in severe palmoplantar pustular psoriasis
J2  - Br J Dermatol
PY  - 2014
VL  - 171
SP  - 646
EP  - 649
UR  - https://doi.org/10.1111/bjd.13012
ER  - 
TY  - JOUR
LB  - 21.
AU  - Viguier, M
AU  - Guigue, P
AU  - Pagès, C
AU  - Smahi, A
AU  - Bachelez, H
TI  - Successful treatment of generalized pustular psoriasis with the interleukin-1-receptor antagonist anakinra: lack of correlation with IL1RN mutations
J2  - Ann Intern Med
PY  - 2010
VL  - 153
SP  - 66
EP  - 67
UR  - https://doi.org/10.7326/0003-4819-153-1-201007060-00030
ER  - 
TY  - JOUR
LB  - 22.
AU  - Cro, S
AU  - Smith, C
AU  - Wilson, R
AU  - Cornelius, V
TI  - Treatment of pustular psoriasis with anakinra: a statistical analysis plan for stage 1 of an adaptive two-staged randomised placebo-controlled trial
J2  - Trials
PY  - 2018
VL  - 19
SP  - 534
UR  - https://doi.org/10.1186/s13063-018-2914-y
ER  - 
TY  - ELEC
LB  - 23.
AU  - Electronic Medicines Compendium
TI  - Kineret 100 mg Solution for Injection in a Pre-Filled Syringe
PY  - 2020
UR  - www.medicines.org.uk/emc/product/559/smpc#UNDESIRABLE_EFFECTS
M1  - 2 December 2020
ER  - 
TY  - JOUR
LB  - 24.
AU  - Cro, S
AU  - Patel, P
AU  - Barker, J
AU  - Burden, DA
AU  - Griffiths, CEM
AU  - Lachmann, HJ
TI  - A randomised placebo controlled trial of anakinra for treating pustular psoriasis: statistical analysis plan for stage two of the APRICOT trial
J2  - Trials
PY  - 2020
VL  - 21
SP  - 158
UR  - https://doi.org/10.1186/s13063-020-4103-z
ER  - 
TY  - ELEC
LB  - 25.
AU  - National Institute for Health and Care Excellence
TI  - Systemic Non-Biological Therapy for Psoriasis
PY  - 2017
UR  - https://pathways.nice.org.uk/pathways/psoriasis#path=view%3A/pathways/psoriasis/systemic-non-biological-therapy-for-psoriasis.xml&content=view-node%3Anodes-drug-choice
M1  - 2 December 2020
ER  - 
TY  - JOUR
LB  - 26.
AU  - Marsland, A
AU  - Chalmers, R
AU  - Hollis, S
AU  - Leonardi-Bee, J
AU  - Griffiths, C
TI  - Interventions for chronic palmoplantar pustulosis
J2  - Cochrane Database Syst Rev
PY  - 2006
VL  - 1
UR  - https://doi.org/10.1002/14651858.CD001433.pub2
ER  - 
TY  - JOUR
LB  - 27.
AU  - Lassus, A
AU  - Geiger, JM
TI  - Acitretin and etretinate in the treatment of palmoplantar pustulosis: a double-blind comparative trial
J2  - Br J Dermatol
PY  - 1988
VL  - 119
SP  - 755
EP  - 759
UR  - https://doi.org/10.1111/j.1365-2133.1988.tb03499.x
ER  - 
TY  - JOUR
LB  - 28.
AU  - Kahan, BC
AU  - Morris, TP
TI  - Reporting and analysis of trials using stratified randomisation in leading medical journals: review and reanalysis
J2  - BMJ
PY  - 2012
VL  - 345
SP  - e5840
UR  - https://doi.org/10.1136/bmj.e5840
ER  - 
TY  - JOUR
LB  - 29.
AU  - Kahan, B
AU  - Morris, TP
TI  - Analysis of multicentre trials with continuous outcomes: when and how should we account for centre effects?
J2  - Stat Med
PY  - 2013
VL  - 32
SP  - 1136
EP  - 1149
UR  - https://doi.org/10.1002/sim.5667
ER  - 
TY  - JOUR
LB  - 30.
AU  - Martin, B
AU  - Altman, D
TI  - Agreement between methods of measurement with multiple observations per individual
J2  - J Biopharm Stat
PY  - 2007
VL  - 17
SP  - 571
EP  - 582
UR  - https://doi.org/10.1080/10543400701329422
ER  - 
TY  - JOUR
LB  - 31.
AU  - McGraw, K
AU  - Wong, S
TI  - Forming inferences about some intraclass correlation coefficients
J2  - Psychol Methods
PY  - 1996
VL  - 1
SP  - 30
EP  - 46
UR  - https://doi.org/10.1037/1082-989X.1.1.30
ER  - 
TY  - JOUR
LB  - 32.
AU  - Moher, D
AU  - Hopewell, S
AU  - Schulz, KF
AU  - Montori, V
AU  - Gøtzsche, PC
AU  - Devereaux, PJ
TI  - CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials
J2  - BMJ
PY  - 2010
VL  - 23
SP  - c869
UR  - https://doi.org/10.1136/bmj.c869
ER  - 
TY  - ELEC
LB  - 33.
AU  - European Medicines Agency
TI  - ICH E9 (R1) Addendum on Estimands and Sensitivity Analysis in Clinical Trials to the Guideline on Statistical Principles for Clinical Trials
PY  - 2017
UR  - www.ema.europa.eu/en/documents/scientific-guideline/draft-ich-e9-r1-addendum-estimands-sensitivity-analysis-clinical-trials-guideline-statistical_en.pdf
M1  - 2 December 2020
ER  - 
TY  - BOOK
LB  - 34.
AU  - Carpenter, J
AU  - Kenward, M
TI  - Missing Data in Randomised Controlled Trials: A Practical Guide
CY  - Birmingham
PB  - Health Technology Assessment Methodology Programme
PY  - 2007
ER  - 
TY  - JOUR
LB  - 35.
AU  - White, IR
AU  - Horton, NJ
AU  - Carpenter, J
AU  - Pocock, SJ
TI  - Strategy for intention to treat analysis in randomised trials with missing outcome data
J2  - BMJ
PY  - 2011
VL  - 342
SP  - d40
UR  - https://doi.org/10.1136/bmj.d40
ER  - 
TY  - JOUR
LB  - 36.
AU  - Zink, RC
AU  - Wolfinger, RD
AU  - Mann, G
TI  - Summarizing the incidence of adverse events using volcano plots and time intervals
J2  - Clin Trials
PY  - 2013
VL  - 10
SP  - 398
EP  - 406
UR  - https://doi.org/10.1177/1740774513485311
ER  - 
TY  - JOUR
LB  - 37.
AU  - Terui, T
AU  - Kobayashi, S
AU  - Okubo, Y
AU  - Murakami, M
AU  - Hirose, K
AU  - Kubo, H
TI  - Efficacy and safety of guselkumab, an anti-interleukin 23 monoclonal antibody, for palmoplantar pustulosis: a randomized clinical trial
J2  - JAMA Dermatol
PY  - 2018
VL  - 154
SP  - 309
EP  - 316
UR  - https://doi.org/10.1001/jamadermatol.2017.5937
ER  - 
TY  - JOUR
LB  - 38.
AU  - Mrowietz, U
AU  - Bachelez, H
AU  - Burden, AD
AU  - Rissler, M
AU  - Sieder, C
AU  - Orsenigo, R
AU  - Chaouche-Teyara, K
TI  - Secukinumab for moderate-to-severe palmoplantar pustular psoriasis: results of the 2PRECISE study
J2  - J Am Acad Dermatol
PY  - 2019
VL  - 80
SP  - 1344
EP  - 1352
UR  - https://doi.org/10.1016/j.jaad.2019.01.066
ER  - 
TY  - JOUR
LB  - 39.
AU  - Fraser, A
AU  - Macdonald-Wallis, C
AU  - Tilling, K
AU  - Boyd, A
AU  - Golding, J
AU  - Davey Smith, G
TI  - Cohort profile: the Avon Longitudinal Study of Parents and Children: ALSPAC mothers cohort
J2  - Int J Epidemiol
PY  - 2013
VL  - 42
SP  - 97
EP  - 110
UR  - https://doi.org/10.1093/ije/dys066
ER  - 
TY  - ELEC
LB  - 40.
AU  - Joint Formulary Committee
TI  - British National Formulary [online]
CY  - London
PB  - BMJ Group and Pharmaceutical Press
UR  - https://bnf.nice.org.uk/drug/anakinra.html#preTreatmentScreeningInformation
ER  - 
TY  - JOUR
LB  - 41.
AU  - Benzian-Olsson, N
AU  - Dand, N
AU  - Chaloner, C
AU  - Bata-Csorgo, Z
AU  - Borroni, R
AU  - Burden, AD
TI  - Association of clinical and demographic factors with the severity of palmoplantar pustulosis
J2  - JAMA Dermatol
PY  - 2020
VL  - 156
SP  - 1216
EP  - 1222
UR  - https://doi.org/10.1001/jamadermatol.2020.3275
ER  - 
TY  - JOUR
LB  - 42.
AU  - Parisi, R
AU  - Iskandar, IYK
AU  - Kontopantelis, E
AU  - Augustin, M
AU  - Griffiths, CEM
AU  - Ashcroft, DM
TI  - National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study
J2  - BMJ
PY  - 2020
VL  - 369
SP  - m1590
UR  - https://doi.org/10.1136/bmj.m1590
ER  - 
TY  - JOUR
LB  - 43.
AU  - Twelves, S
AU  - Mostafa, A
AU  - Dand, N
AU  - Burri, E
AU  - Farkas, K
AU  - Wilson, R
TI  - Clinical and genetic differences between pustular psoriasis subtypes
J2  - J Allergy Clin Immunol
PY  - 2019
VL  - 143
SP  - 1021
EP  - 1026
UR  - https://doi.org/10.1016/j.jaci.2018.06.038
ER  - 
TY  - JOUR
LB  - 44.
AU  - Vergnano, M
AU  - Mockenhaupt, M
AU  - Benzian-Olsson, N
AU  - Paulmann, M
AU  - Grys, K
AU  - Mahil, SK
TI  - Loss-of-function myeloperoxidase mutations are associated with increased neutrophil counts and pustular skin disease
J2  - Am J Hum Genet
PY  - 2020
VL  - 107
SP  - 539
EP  - 543
UR  - https://doi.org/10.1016/j.ajhg.2020.06.020
ER  - 
TY  - JOUR
LB  - 45.
AU  - Bachelez, H
AU  - Choon, SE
AU  - Marrakchi, S
AU  - Burden, AD
AU  - Tsai, TF
AU  - Morita, A
TI  - Inhibition of the interleukin-36 pathway for the treatment of generalized pustular psoriasis
J2  - N Engl J Med
PY  - 2019
VL  - 380
SP  - 981
EP  - 983
UR  - https://doi.org/10.1056/NEJMc1811317
ER  - 
TY  - JOUR
LB  - 46.
AU  - Hudock, KM
AU  - Collins, MS
AU  - Imbrogno, M
AU  - Snowball, J
AU  - Kramer, EL
AU  - Brewington, JJ
TI  - Neutrophil extracellular traps activate IL-8 and IL-1 expression in human bronchial epithelia
J2  - Am J Physiol Lung Cell Mol Physiol
PY  - 2020
VL  - 319
SP  - L137
EP  - L147
UR  - https://doi.org/10.1152/ajplung.00144.2019
ER  - 
TY  - JOUR
LB  - 47.
AU  - Mrowietz, U
AU  - Burden, AD
AU  - Pinter, A
AU  - Reich, K
AU  - Schäkel, K
AU  - Baum, P
TI  - Spesolimab, an anti-interleukin-36 receptor antibody, in patients with palmoplantar pustulosis: results of a phase IIa, multicenter, double-blind, randomized, placebo-controlled pilot study
J2  - Dermatol Ther
PY  - 2021
VL  - 11
SP  - 571
EP  - 585
UR  - https://doi.org/10.1007/s13555-021-00504-0
ER  - 
TY  - ELEC
LB  - 48.
AU  - AnaptysBio, Inc
TI  - AnaptysBio Reports Imsidolimab POPLAR Phase 2 Clinical Trial in Moderate-to-Severe Palmoplantar Pustulosis (PPP) Did Not Meet Primary Endpoint
PY  - 2021
UR  - https://ir.anaptysbio.com/news-releases/news-release-details/anaptysbio-reports-imsidolimab-poplar-phase-2-clinical-trial
M1  - 17 March 2021
ER  - 
TY  - ELEC
LB  - 49.
AU  - National Institute for Health and Care Excellence
TI  - Psoriasis: Assessment and Management
PY  - 2017
UR  - www.nice.org.uk/guidance/cg153
M1  - 7 December 2020
ER  -